Vanda Pharmaceuticals, Inc. (VNDA)
5.43
+0.09
(+1.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.43
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Price to Book Value : 1.491 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 1.491 |
| September 03, 2026 | 1.466 |
| September 02, 2026 | 1.518 |
| September 01, 2026 | 1.488 |
| August 31, 2026 | 1.483 |
| August 28, 2026 | 1.452 |
| August 27, 2026 | 1.494 |
| August 26, 2026 | 1.469 |
| August 25, 2026 | 1.494 |
| August 24, 2026 | 1.463 |
| August 21, 2026 | 1.450 |
| August 20, 2026 | 1.477 |
| August 19, 2026 | 1.529 |
| August 18, 2026 | 1.494 |
| August 17, 2026 | 1.444 |
| August 14, 2026 | 1.433 |
| August 13, 2026 | 1.381 |
| August 12, 2026 | 1.425 |
| August 11, 2026 | 1.354 |
| August 10, 2026 | 1.378 |
| August 07, 2026 | 1.373 |
| August 06, 2026 | 1.404 |
| August 05, 2026 | 1.398 |
| August 04, 2026 | 1.463 |
| August 03, 2026 | 1.436 |
| Date | Value |
|---|---|
| July 31, 2026 | 1.400 |
| July 30, 2026 | 1.422 |
| July 29, 2026 | 1.386 |
| July 28, 2026 | 1.417 |
| July 27, 2026 | 1.433 |
| July 24, 2026 | 1.422 |
| July 23, 2026 | 1.472 |
| July 22, 2026 | 1.469 |
| July 21, 2026 | 1.505 |
| July 20, 2026 | 1.461 |
| July 17, 2026 | 1.494 |
| July 16, 2026 | 1.496 |
| July 15, 2026 | 1.606 |
| July 14, 2026 | 1.606 |
| July 13, 2026 | 1.647 |
| July 10, 2026 | 1.713 |
| July 09, 2026 | 1.752 |
| July 08, 2026 | 1.807 |
| July 07, 2026 | 1.754 |
| July 06, 2026 | 1.710 |
| July 02, 2026 | 1.705 |
| July 01, 2026 | 1.661 |
| June 30, 2026 | 1.680 |
| June 29, 2026 | 1.315 |
| June 26, 2026 | 1.287 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Protagonist Therapeutics, Inc. | 11.20 |
| ACADIA Pharmaceuticals, Inc. | 3.691 |
| Alnylam Pharmaceuticals, Inc. | 26.28 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
Price to Book Value Related Metrics
| PS Ratio | 1.497 |
| PEG Ratio | -0.0038 |
| Price | 5.43 |
| Earnings Yield | -85.19% |
| Market Cap | 328.27M |
| PEGY Ratio | -0.0038 |